A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh
- DOI
- 10.1016/j.vaccine.2021.06.069
- Published
- 2021-07
- Container
- Vaccine
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.vaccine.2021.06.069,
title = {A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh},
author = {Fahima Chowdhury and Khalid Ali Syed and Afroza Akter and Taufiqur Rahman Bhuiyan and Imam Tauheed and Fatema Khaton and Rajib Biswas and Jannatul Ferdous and Hasan Al Banna and Allen G. Ross and Nigel Mc Millan and Tarun Sharma and Vibhu Kanchan and Ajit Pal Singh and Davinder Gill and Michael Lebens and Stefan Nordqvist and Jan Holmgren and John D Clemens and Firdausi Qadri},
year = {2021},
journal = {Vaccine},
doi = {10.1016/j.vaccine.2021.06.069},
url = {https://doi.org/10.1016/j.vaccine.2021.06.069}
}RIS
TY - JOUR TI - A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh AU - Fahima Chowdhury AU - Khalid Ali Syed AU - Afroza Akter AU - Taufiqur Rahman Bhuiyan AU - Imam Tauheed AU - Fatema Khaton AU - Rajib Biswas AU - Jannatul Ferdous AU - Hasan Al Banna AU - Allen G. Ross AU - Nigel Mc Millan AU - Tarun Sharma AU - Vibhu Kanchan AU - Ajit Pal Singh AU - Davinder Gill AU - Michael Lebens AU - Stefan Nordqvist AU - Jan Holmgren AU - John D Clemens AU - Firdausi Qadri PY - 2021 JO - Vaccine DO - 10.1016/j.vaccine.2021.06.069 UR - https://doi.org/10.1016/j.vaccine.2021.06.069 ER -
APA
Chowdhury, F., Syed, K. A., Akter, A., Bhuiyan, T. R., Tauheed, I., Khaton, F., Biswas, R., Ferdous, J., Banna, H. A., Ross, A. G., Millan, N. M., Sharma, T., Kanchan, V., Singh, A. P., Gill, D., Lebens, M., Nordqvist, S., Holmgren, J., Clemens, J. D., & Qadri, F. (2021). A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh. Vaccine. https://doi.org/10.1016/j.vaccine.2021.06.069
Source records
- crossref · retrieved 2026-09-26T21:53:39.538Z